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Summary This study focuses on the use of buthionine sulphoximine (BSO), a g-glutamylcysteine synthetase inhibitor,
on Leishmania donovani growth. The effect of BSO on amastigote multiplication within macrophages
showed that 5 mm BSO decreased infectivity by about 50% and the mean number of amastigotes per 100
infected macrophages by 21%. The mechanism may be that BSO resulted in enhanced nitric oxide (NO)
levels within macrophages, probably due to inhibition of GSH content since GSH (10 mM) given after BSO
treatment led to a decrease in NO compared to macrophages treated with BSO alone which were preexposed
to the Leishmania surface molecule lipophosphoglycan.
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Introduction
Glutathione (l-g-glutamyl-l-cysteinyl-glycine; GSH) is a
tripeptide thiol present in virtually all cells, which performs a
number of vital functions such as reduction of disulphide
linkages of proteins and other molecules (Meister 1983, 1988,
1995; Anderson 1997). It is also involved in the synthesis of
deoxyribonucleotide precusors of DNA and in the protection
of cells against the effects of free radicals and of reactive
oxygen intermediates formed during metabolic processes
(Anderson 1997). GSH has a role in inactivation of drugs and
metabolic processing of certain endogenous compounds such
as oestrogens and prostaglandins (Meister 1983). Thus in-
hibition of this thiol is an important mechanism for meta-
bolic inactivation of cells.
In the case of trypanosomes and Leishmania, no gluta-
thione reductase is found although GSH is present. Gluta-
thione reductase maintains glutathione disulphide (GSSG) as
glutathione (GSH) in these cells (Fairlamb & Cerami 1985).
Instead these organisms reduce GSSG and other disulphides
by means of nonenzymatic thiol–disulphide exchange with
trypanothione, a low molecular weight dithiol unique to
them (Fairlamb et al. 1985). Trypanothione (N1, N8-bis
(glutathionyl) spermidine) is maintained intracellularly as a
dithiol (T[SH]2), due to the action of the unique enzyme,
trypanothione reductase. In logarithmically growing cells,
trypanothione accounts for . 68% of intracellular GSH in
Trypanosoma brucei bloodstream and procyclic forms
(Fairlamb & Henderson 1987) and in Leishmania species
(Keithly & Fairlamb 1988). Consequently it is of great inter-
est as a target for drug development. Biosynthesis of trypano-
thione proceeds from glutathione and spermidine principally
via the intermediate N1-glutathionyl spermidine (GSH-SPD).
Since GSH performs various protective functions within cells
(Meister & Anderson 1983; Meister 1983), selective inhi-
bition of this metabolite is an important chemotherapeutic
strategy for kala-azar.
Glutathione is an integral part of most mammalian sys-
tems and its general function is oxidative defence. It is present
in both host and leishmanial systems. Thus if it is used as a
target for chemotherapy there is a danger of host toxicity.
However, some GSH inhibitors such as l-buthionine sulph-
oximine (BSO) have been successfully used in vivo against
Trypanosoma in female Swiss Webster mice (Arrick et al.
1981). BSO is a drug with no known mammalian toxicity and
with little intrinsic chemical reactivity. It apparently acts
solely through inhibition of GSH synthesis and thus does not
directly affect other cellular thiols (Griffith 1981). Earlier
reports have shown that parasites and hosts have markedly
different requirements for GSH (Hussein & Walter 1996).
This criterion may be applied in the development of drugs
against parasitic infections.
This study focuses on the use of buthionine sulphoximine
(BSO), a g-glutamylcysteine synthetase inhibitor, on
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Leishmania donovani amastigote multiplication within the
host macrophages, and its mechanism of action.
Materials and methods
Chemicals
Tissue culture chemicals (adenine, biotin, folic acid, haemin,
hepes, M-199, minimal essential medium (alpha modifi-
cation), penicillin, RPMI-1640, sodium bicarbonate, strepto-
mycin, etc.) and l-buthionine sulphoximine were procured
from Sigma Chemical Co., St Louis, MO, USA. Fetal calf
serum was purchased from Biological Industries, Kibbutz
Beet Haemek, Israel.
Parasites
Leishmania donovani (strain AG83)
(MHOM,IN,1983/AG83) was maintained in the laboratory
in medium M-199 containing 10% fetal calf serum (FCS).
Golden hamsters were infected intracardially with 107
Leishmania donovani (AG83, MHOM,IN,1983/AG83) pro-
mastigotes. After 3 months of infection, amastigotes from
infected spleens were transformed into promastigotes in
M-199 medium containing 30% FCS at 22 8C with con-
tinuous shaking. These freshly transformed promastigotes
were then freed of spleen cells by differential centrifugation
and suspended in RPMI-1640 medium with 10% FCS before
using them for the amastigote transformation study.
Drug study
BSO was dissolved in autoclaved water and filter sterilized
before addition to the medium containing parasites. The tox-
icity of the inhibitor was determined by adding a range of
drug concentrations (0–20 mm) to a suspension of 1 3 106
promastigotes per ml of a-MEM medium and incubating
them at 22 8C for 48 h. Triplicate incubations in the absence
of drug were maintained in parallel as controls. The proto-
zoal counts were taken using a Neubauer haemocytometer.
Effect of BSO on J774A.1 murine macrophages in vitro
J774A.1, a murine macrophage cell line, was maintained in
RPMI-1640 medium with 10% FCS. Macrophages were
plated in tissue culture plates at a cell density of 1 3 106
cells/ml and incubated in a CO2 incubator (5% CO2) at 37 8C.
After 24 h, the filter-sterilized drug at different concentrations
was added to the macrophages and they were again incubated
at 37 8C for 48 h. At this stage, the percentage of live cells in
all the groups was determined. Triplicate samples were used
for these studies and the data was expressed as mean 6 SD of
percentage of control values.
Effect of BSO on intracellular amastigote multiplication
The effect of BSO on intracellular amastigote multiplication
was studied using the method of Baumann et al. (1990).
Briefly, macrophages were plated onto adherent petridishes at
a density of 1 3 106 cells/ml and incubated overnight at 37 8C
in a CO2 incubator (5% CO2). Parasites were added onto the
macrophages at a ratio of 10 : 1 and the plates were reincu-
bated at 37 8C for 3 h. Thereafter the excess promastigotes
were washed off and the plates incubated at 37 8C for another
12 h to permit transformation of all promastigotes into
amastigotes. At this stage, the drug was added to the plates
and they were kept at 37 8C. The drug was replenished on the
3rd, 5th and 7th days. On the 10th day, the plates were har-
vested for microscopic examination. The data was expressed
as the percentage of infected macrophages 6 sd and the
mean number of amastigotes per 100 infected macrophages
6 sd. These results are representative of triplicate samples.
Nitric oxide assay
J774A.1 macrophages were seeded into 96 well tissue culture
plates at a density of 5 3 105 cells/well and kept in a CO2
incubator (5% CO2) for 12 h at 37 8C. Leishmania lipophos-
phoglycan (LPG) (5 mg/ml) was added to the requisite wells
and the plate was again incubated at 37 8C for 12 h before
adding BSO (5 mM) to the wells and reincubating the plate
for 12 h under similar conditions. GSH (10 mm) was added to
the wells and the plate reincubated at 37 8C for 12 h, after
which the samples were harvested for nitric oxide assay
(Green et al. 1982). Results are derived from triplicate
samples.
Statistical analysis
All experiments were performed in triplicate. In the micro-
scopic studies, a minimum of 200 cells were screened in each
culture and the percentage of infected cells and the average
number of amastigotes per 100 infected cells was recorded.
Results were expressed as mean 6 sd of triplicate samples at
each time point. Student’s t-test was performed to determine
the level of significance and P , 0.05 was considered to be
significant.
Results
The antileishmanial effect of BSO was assessed in promasti-
gote and amastigotes. A 1.0-mm and a 5-mm concentration
of BSO resulted in almost 30% and 60% inhibition of pro-
mastigote growth, respectively. No additional inhibition with
higher concentration of BSO was observed (results not
shown).
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Since the parasite survives in the intralysosomal compart-
ment of the host macrophages, it was of interest to study the
effect of BSO on intracellular amastigote multiplication
within bone marrow macrophages. Table 1 shows the effect
of BSO on amastigote multiplication within bone marrow
macrophages. Concentrations as low as 5 mm significantly
affected infectivity (P , 0.001). BSO (5 mm) decreased infec-
tivity by about 50% and the mean number of amastigotes per
100 infected macrophages by 21% (P , 0.01).
Regarding the effect of BSO on a J774A.1 murine macro-
phage cell line in vitro at 48 h of drug treatment, a concen-
tration of 10 mm was found to inhibit macrophage growth
by 20% of control values. A concentration of 50 mm BSO
decreased macrophage growth by only 25%. This indicates
that the concentrations of BSO used to inhibit the parasite
are only moderately effective against the host system.
Table 2 shows the effect of BSO on the stimulation of
nitric oxide in bone marrow macrophages. Since induction of
NO is a mechanism involved in defence against parasites, it
was of interest to study the mechanism of action of BSO
against intracellular amastigotes. BSO (5 mm) treatment led
to a significant increase in the nitric oxide levels within
murine bone marrow macrophages (P , 0.001). LPG
(5 mg/ml), the surface molecule of the parasite, had no signifi-
cant effect on NO levels. However, when BSO was adminis-
tered after LPG treatment, there was a significant increase in
NO over LPG alone values (P , 0.001). Treatment with GSH
(10 mm) completely inhibited nitric oxide levels in
macrophages. GSH (10 mm) also reduced the effect of BSO
on nitric oxide stimulation in macrophages. This indicates
that GSH depletion of macrophages by BSO is responsible for
parasite killing by increasing NO in macrophages.
Discussion
The rising incidence of visceral leishmaniasis throughout the
world and the emergence of resistance to commonly used
antimonials has led to an urgent need for new and more
potent chemotherapeutic agents against this disease. The
trypanothione biosynthetic pathway is common to the
Treatment* Mean percentage Mean number of amastigotes per 
(mm) infected cells 6 sd (%R) 100 infected macrophages 6 sd (% R)
Control 57 6 1 167 6 14
BSO (5 mm) 30 6 3 (47)b 132 6 11 (21)a
*Cultures of macrophages were incubated with L. donovani at 37 8C for 3 h. After the free
organisms were removed, the cultures were incubated for another 12 h to enable all the pro-
mastigotes to get transformed into amastigotes. At this time, macrophages received RPMI
either alone or containing BSO. The inhibitor was replenished on days 3, 5 and 7 of the experi-
ment. Sets of triplicate samples each were terminated on day 10. The slides were processed for
microscopic examination. These results are representative of triplicate samples.
*Significant decrease over control (P , 0.01–0.001).
Table 1 Effect of BSO on intracellular
amastigote multiplication of L. donovani
within host macrophages in vitro
Mean 6 sd of nitric oxide
Treatment* (mm/106 cells)
Control 6.5 6 0.1
LPG (5 mg/ml) 6.0 6 0.1†
BSO (5 mm) 44.3 6 6.8‡
LPG (5 mg/ml) 1 BSO (5 mm) 36.7 6 0.8‡
GSH (10 mm) 0.0 6 0.0§
BSO (5 mm) 1 GSH (10 mm) 4.7 6 0.7†
LPG (5 mg/ml) 1 BSO (5 mm) 1 GSH (10 mm) 24.2 6 1.3‡
*Nonsignificant over control values.
†Bone marrow macrophages were treated with LPG (5 mg/ml) for 12 h at 37 8C in a CO2 incu-
bator followed by BSO (5 mM) treatment for 12 h and treatment with GSH (10 mm) for 12 h;
then nitric oxide levels were measured. These results are representative of triplicate samples.
‡Significant increase over control (P , 0.001).
§Significant decrease over control (P , 0.001).
Table 2 Effect of BSO on nitric oxide
elicitation by LPG pretreated bone marrow
macrophages
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trypanosomatid family of protozoa, which includes
Leishmania and Trypanosoma; and is absent in the host
systems. Thus this pathway constitutes an important target
for chemotherapy against kala-azar. The trypanothione path-
way combines two metabolic pathways – the polyamine
biosynthetic pathway and the glutathione pathway. Since
glutathione (GSH) is involved in a number of vital functions
within cells, chiefly defence against oxidative damage, GSH
inhibition is a potential means for chemotherapy of these
parasites.
GSH biosynthesis is most effectively inhibited by buthi-
onine sulphoximine (BSO), a tightly bound inhibitor of
g-glutamylcysteine synthetase, the enzyme catalysing the first
step of GSH biosynthesis. BSO has been found to have no
apparent effects other than depletion of GSH when adminis-
tered to mice or rats by subcutaneous or intraperitoneal injec-
tion (Griffith 1981). Another advantage in using BSO was
that this inhibitor has no known mammalian toxicity and has
little intrinsic chemical reactivity. Also it apparently acts
solely via inhibition of GSH biosynthesis and thus does not
directly affect other cellular thiols (Arrick et al. 1981).
The antitrypanosomal effect of BSO was explored by
Arrick et al. (1981). They found that when BSO was adminis-
tered to female Swiss Webster mice infected with Trypano-
soma brucei brucei and trypanosomes were isolated from the
blood of these mice, they were found to have depleted GSH
levels. The parasite could not be identified in blood samples
collected 16–18 h after BSO administration was begun.
We found BSO to be an effective antileishmanial agent
against Leishmania donovani promastigotes in vitro which
also inhibited intracellular amastigote multiplication.
Macrophage inhibitory studies showed that at the concen-
trations used for promastigote inhibition, the inhibitor had
minimal effect on the macrophages. Weldrick et al. (1999)
have recently reported that amastigotes were less susceptible
than promastigotes to the effect of redox cyclers paraquat
and menadione in the presence of 20 mm BSO which blocked
the synthesis of glutathione. The results reported by this
group suggest that there are factors other than, or in addition
to, possession of abundant levels of intracellular thiols that
may be responsible for the survival and replication of
amastigotes in culture (Weldrick et al. 1999).
Earlier reports have described the effect of the parasite on
nitric oxide levels in macrophages (Evans et al. 1993). Macro-
phages produce high levels of nitric oxide from l-arginine on
stimulation by lipopolysaccharide (LPS) or cytokines such as
IFN-g (Stuehr & Marletta 1985, 1987; Hibbs et al. 1988). The
killing of several intracellular pathogens has been shown to
be dependent on NO production by macrophages (Evans
et al. 1993). The role of nitric oxide in the killing of Leish-
mania major is well established (Evans et al. 1993; Severn et
al. 1993; Stefani et al. 1994). We studied the effect of pre-
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exposure to LPG, a surface molecule of Leishmania on nitric
oxide synthesis and the effect of BSO on NO production in
LPG pre-exposed macrophages. GSH has a protective role
against the antiproliferative effects of nitric oxide in tumour
cells (Petit et al. 1996). BSO reverses the protective effect of
GSH in tumour cells (Petit et al. 1996). Pretreatment with
BSO, which is an inhibitor of GSH synthesis, greatly increases
the sensitivity of tumour cells to the antiproliferative effects
of several NO-donating compounds (Petit et al. 1996). The
results of this study clearly show that the Leishmania surface
molecule LPG by itself has no effect on NO synthesis, which
could be the reason why the parasite successfully survives
within the macrophages of the vertebrate host (Proudfoot
et al. 1995, 1996). Previous reports have shown that GSH is a
scavenger of reactive oxygen (ROS) and nitrogen species
(RNOS) (Luperchio et al. 1996; Petit et al. 1996). Since BSO
depletes GSH content, it leads to an increase in free radicals
and reactive nitrogen species in the system (Graier et al. 1996;
Suzuki et al. 1997). Our study confirms this since GSH
(10 mM) completely depleted macrophages of nitric oxide.
BSO (5 mM), on the other hand, resulted in enhanced NO
levels within macrophages, probably due to inhibition of
GSH content. GSH (10 mM), when given after BSO treatment,
led to a decrease in NO compared to macrophages treated
with BSO alone which were pre-exposed to LPG. The potent
antileishmanial effect of this inhibitor at the in vitro level and
its selective inhibitory activity towards the parasite make it a
probable chemotherapeutic agent against kala-azar.
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